Biologic medicine inclusion in 138 national essential medicines lists

• Автори: Raphaël Kraus (Автор), Rae S. M. Yeung (Автор), Nav Persaud (Автор)
• Формат: Книга
• Опубліковано: BMC, 2021-09-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Abstract Background Essential medicines lists (EMLs) are intended to reflect the priority health care needs of populations. We hypothesized that biologic disease-modifying antirheumatic drugs (DMARDs) are underrepresented relative to conventional DMARDs in existing national EMLs. We aimed to survey...